Cbl-b-IN-5
Product Specifications
UNSPSC Description
Cbl-b-IN-5 (compound 6) is a Cbl-b inhibitor (IC50=3-10 µM). Cbl-b-IN-5 has the potential to be used in the study of cancer and related diseases amenable to immune system modulation[1].
Target Antigen
E1/E2/E3 Enzyme
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cbl-b-in-5.html
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC(C1=CC(NC(C2=NC=CC=C2)=O)=CC=C1)SC3=NN=CN3C
Molecular Weight
339.41
References & Citations
[1]Paul A. Barsanti, et al. Inhibitors of cbl-b and methods of use thereof. Patent WO2019148005A1.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-155120/Cbl-b-IN-5-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-155120/Cbl-b-IN-5-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2368835-59-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Polyclonal ERH Antibody [PE]](https://cdn.genprice.uk/genprice/genprice5.png)
MBS1248115 Inquire
Recombinant Influenza B virus RNA-directed RNA polymerase catalytic subunit (PB1), partial
Ask
View Details